Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom

BMJ : British Medical Journal
UK Colorectal Cancer Screening Pilot Group

Abstract

To assess the feasibility of introducing into the UK's NHS a national screening programme for colorectal cancer based on faecal occult blood testing. Demonstration pilot. Two English health authorities and three Scottish health boards. People aged 50-69 years. 478,250 residents of the pilot areas were invited to take part in the screening programme. Uptake (the proportion in whom a final faecal occult blood test result was available) was 56.8% (n = 271,646). The overall rate of a positive test result was 1.9% and the rate for detecting cancer was 1.62 per 1000 people screened. Both these values were higher in Scotland than in England, higher in men than in women, and increased with age. The positive predictive value was 10.9% for cancer and 35.0% for adenoma. 552 cancers were detected by screening; 92 (16.6%) were polyp cancers. 48% of all screen detected cancers were Dukes's stage A, and 1% had metastasised at the time of diagnosis. Screening for colorectal cancer by testing for faecal occult blood is feasible within the context of the United Kingdom's NHS. Screening should lead to a reduction in deaths from colorectal cancer in the population offered screening.

References

Jun 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·T O TengsJ D Graham
Sep 11, 1995·Archives of Internal Medicine·A D Müller, A Sonnenberg
Apr 16, 1998·Health Economics·D Gyrd-HansenO Kronborg
Feb 16, 2000·Lancet·H J de Koning
Dec 12, 2001·Journal of Advanced Nursing·S PathmakanthanM Donnelly
Dec 18, 2001·Journal of Medical Screening·R J SteeleUNKNOWN United Kingdom Colorectal Screening Pilot Group
Apr 20, 2002·Lancet·W S AtkinUNKNOWN UK Flexible Sigmoidoscopy Screening Trial Investigators
Sep 11, 2002·Gut·W S AtkinUNKNOWN Association of Coloproctology for Great Britain and Ireland

❮ Previous
Next ❯

Citations

Jun 3, 2006·Diseases of the Colon and Rectum·Michael R ThompsonW S Atkin
Nov 28, 2013·The Lancet Oncology·John K FieldDavid R Baldwin
May 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N AscunceUNKNOWN Network of Spanish Cancer Screening Programmes (Red de Programas Espanoles de Cribado de Cancer)
Jun 29, 2011·Epidemiologic Reviews·Theodore R LevinCindy Caldwell
Nov 28, 2009·Family Practice·Jane MeliaDerek Coleman
Dec 18, 2009·Journal of Public Health·My von Euler-ChelpinElsebeth Lynge
Apr 17, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·R A SmithP S Carter
Feb 15, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·N WardJ Norton
Sep 15, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S MassonA D Dwarakanath
Oct 25, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·N J WestR J Leicester
Feb 18, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·C HarmstonL Wong
Apr 4, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·C HarmstonL Wong
Oct 22, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·P EllulA M Veitch
Jan 22, 2010·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J HunterL Wong
Jul 16, 2010·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·R Fisher, P S Rooney
Sep 24, 2010·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·P J ConaghanA G Acheson
Jun 22, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S GuptaS Thomas-Gibson
Oct 11, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·A CarreraR J C Steele
May 5, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·P T RajasekharC J Rees
May 29, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·C S D RoxburghR H Diament
Jun 8, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·R PandeC Harmston
Jun 20, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·E D CourtneyJ Hernon
Jul 11, 2006·BMJ : British Medical Journal·David Weller
Dec 14, 2011·Gut·Richard F A LoganUNKNOWN English Bowel Cancer Screening Evaluation Committee
Dec 19, 2006·Journal of Clinical Pathology·W S A SmellieC van Heyningen
Jan 29, 2008·BMC Public Health·Kathryn A RobbJane Wardle
Apr 29, 2010·BMC Health Services Research·Charlotte L PriceJulietta Patnick
Sep 12, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ryan ZarychanskiPaul C Hébert
Jan 22, 2011·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jung Im ShimEun-Cheol Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.